Companies / Amylyx Pharmaceuticals, Inc. / Activity
Activity — Amylyx Pharmaceuticals, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $196.3K | +14K | 14,120 0.01% of shares | low |
| Q1 2026 as of | Amundi 13F manager | New | Common stock | $179.2K | +13K | 12,895 0.01% of shares | low |
| Q1 2026 as of | Great Lakes Advisors, LLC 13F manager | New | Common stock | $144.3K | +10K | 10,380 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $125.3K | +9K | 9,014 <0.01% of shares | low |
| Q1 2026 as of | Eastern Bank 13F manager | New | Common stock | $2.8K | +200 | 200 <0.01% of shares | low |
| Q2 2026 as of | SG Americas Securities, LLC 13F manager | New | Common stock | $994 | +55K | 55,321 0.05% of shares | low |
| Q2 2026 as of | Covestor Ltd 13F manager | New | Common stock | $1 | +33 | 33 <0.01% of shares | low |